Name: Drug Development
Brand: University of California San Diego
Availability: OnlineOnly
Rating: 4.7 (484 reviews)

返回到 Drug Development

学生对 University of California San Diego 提供的 Drug Development 的评价和反馈

4.7

星

2,423 个评分

课程概述

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primarily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data generated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://hua.dididi.sbs/learn/drug-discovery), Drug Development and Drug Commercialization (https://hua.dididi.sbs/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

476 - Drug Development 的 484 个评论（共 484 个）

创建者 Maria B

•

Mar 18, 2020

The course is not prepared for online course

创建者 Benoit E

•

Feb 21, 2019

A lot too much bla bla on the Phase iv part

创建者 GHAIDA D M A G D M A

•

Oct 23, 2025

The quiz is not working

创建者 Michael M

•

Sep 9, 2020

I only looked at the slides, as I wanted to confirm, what I read in some of the reviews. A standard issue on Coursera is, that material is not maintained and updated. I have worked in the pharmaceutical industry for more than 15 years now and everything is constantly evolving. The world of 2013 is not the world of 2020 and course material should e updated regularly.

创建者 Ananya S

•

Jul 13, 2020

The data shown in the lecture and even the lecture itself is dated back to 2012. Kindly upload an updated lecture with new rules, recent data, recent examples. It would be of great help.